BSETrident Lifeline Ltd· Pharmaceuticals & BiotechnologyHighPositive
Announced Thu, 12 Jun, 2025 · 10:22 IST

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gajera Mohak & PACs

Promoter Stake BuyOwnership Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.8%Reaction day
₹272.60
prior close
—
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.5%-1.3% vs market
Pharmaceuticals peers, median of 148sector-0.5%-2.4% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 2.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.8-1.5-1.3-0.5-2.4
Next day
-1.0-1.8+0.9-0.8-0.1
2d
—-1.5—-1.1—
3d
—-2.5—-2.2—
4d
-1.0-2.8+1.8-2.8+1.8
5d
—-4.6—-4.5—
1w
+0.9-4.0+4.9-4.0+4.8
15d
-1.0-0.4-0.6-1.1+0.2
1m
-2.1-0.1-2.0-0.6-1.5
2m
+2.0-4.8+6.8-4.9+6.9
3m
+4.0-2.1+6.2-2.6+6.6
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 148Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gajera Mohak, along with 12 persons acting in concert (all promoters/promoter group entities), has disclosed the acquisition of 6,13,400 convertible equity warrants of Trident Lifeline Ltd under a preferential offer dated June 9, 2025. Key allottees include Hardik Desai Family Trust (1,89,000 warrants), Amit Bhupendra Halvawala (1,39,800), Maniya H Desai (99,000), Rupaben Chetanbhai Jariwala (46,800), Trident Texofab Limited (36,000), Vishal Bhupendra Halvawala (30,000) and others. The company's existing equity share capital is Rs 11,49,92,000 (1,14,99,200 shares of Rs 10 each), and total diluted capital post-allotment is Rs 12,49,34,000 (1,24,93,400 shares), reflecting the warrant component. The disclosure confirms promoter group entities are the allottees in this preferential issue, reinforcing their commitment to the company.

Likely market impact

This is a promoter-group preferential warrant allotment, which signals promoter confidence in the business and will increase the effective promoter shareholding once warrants are converted. However, it also dilutes non-promoter shareholders' stake on conversion, and warrants are being issued at terms set by the promoter group, which retail investors should review in the accompanying notice.